Evoked mid-frontal activity predicts cognitive dysfunction in Parkinson's disease
Arun Singh1, Rachel C Cole2, Arturo I Espinoza2
1Division of Basic Biomedical Sciences, University of South Dakota, Vermillion, South Dakota, USA arun.singh@usd.edu.
Journal of Neurology, Neurosurgery, and Psychiatry
|June 1, 2023
Summary
Cognitive dysfunction in Parkinson's disease (PD) is linked to reduced mid-frontal delta/theta brain rhythms. These findings may lead to new biomarkers and treatments for PD cognitive symptoms.
Area of Science:
- Neuroscience
- Cognitive Science
- Neurology
Background:
- Cognitive dysfunction is a key feature of Parkinson's disease (PD), with unknown causes.
- Abnormal low-frequency cortical rhythms are implicated in cognitive functions and are impaired in PD.
- This study investigates if mid-frontal delta/theta rhythms predict cognitive dysfunction in PD.
Purpose of the Study:
- To test the hypothesis that mid-frontal delta/theta rhythms predict cognitive dysfunction in Parkinson's disease.
- To explore the relationship between electroencephalography (EEG) rhythms and cognitive performance in PD patients.
- To identify potential biomarkers for cognitive deficits in PD.
Main Methods:
- Recruited 100 PD patients and 49 controls for cognitive tasks (Simon, oddball, interval-timing).
- Measured cue-evoked delta (1-4 Hz) and theta (4-7 Hz) rhythms from a mid-frontal EEG electrode (Cz).
- Analyzed EEG data in PD patients categorized by cognitive status (normal, mild cognitive impairment, dementia).
Main Results:
- PD-related cognitive dysfunction correlated with increased response latencies and decreased mid-frontal delta power.
- Principal component analysis of EEG features at Cz strongly correlated with cognitive assessment scores (MoCA, NIH Toolbox Executive Function).
- Specific correlations found between EEG features and clinical metrics (r=0.34 for MoCA, r=0.46 for NIH Toolbox).
Conclusions:
- Cue-evoked mid-frontal delta/theta rhythms are directly associated with cognition in Parkinson's disease.
- PD cognitive dysfunction may stem from diminished delta/theta activity in frontal brain regions.
- Findings suggest potential for novel biomarkers and targeted therapies for cognitive symptoms in PD.
Related Concept Videos
Parkinson's Disease: Overview
614
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
614
Parkinson's Disease: Treatment
308
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
308
Neural Regulation
39.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K
Role of Cerebellum and Prefrontal Cortex in Memory
508
The cerebellum, while traditionally associated with motor control, also plays a crucial role in memory, particularly in procedural memory, which involves learning motor tasks that become automatic through repetition. For example, studies have shown that when the cerebellum is damaged, individuals or animals lose the ability to learn conditioned motor responses, such as the conditioned eye-blink response in classical conditioning experiments with rabbits. This study demonstrates the...
508
Alzheimer's Disease: Overview
539
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
539


